Creating Healthy Future, Together!

Founded in June 2022, APDM Pharmaceuticals emerged as a bold vision of visionary entrepreneurs and seasoned scientists determined to reshape the pharmaceutical landscape. With a commitment to cutting-edge innovation, uncompromising quality, and ethical partnerships, we rapidly positioned ourselves as a dynamic force in the industry.

Within just 15 months, we established a state-of-the-art 15,000-square-meter facility near Ahmedabad, marking a significant milestone in our journey to create a world-class, research-driven organization. By mid-2023, our advanced R&D center was operational, staffed with a highly skilled team of 50+ scientists specializing in formulation development, patent landscaping, and global regulatory compliance.

What We Believe

Our Purpose

We aim to

  • Comprehensive Pharma Solutions – A one-stop, value-added partner delivering innovative, high-quality medicines.
  • Excellence & Ethics – Driven by scientific expertise, ethical business practices, and strategic collaborations.
  • Advancing Healthcare – Accelerating medical progress for better global access to effective treatments.

Our Vision

To create a future-ready healthcare ecosystem driven by:

  • IoT-enabled manufacturing for enhanced efficiency and scalability.
  • Cutting-edge R&D to push the boundaries of pharmaceutical innovation.
  • Uncompromising quality standards to redefine patient outcomes worldwide.

Our Core Values

Innovation

Pioneering pharmaceutical advancements through breakthrough science and cutting-edge technology.​

Quality

Upholding global cGMP standards and data integrity to ensure safety, efficacy, and reliability.​

Future-Ready

Integrating Industry 4.0 technologies, IoT-driven process controls, and advanced analytics for operational excellence.​

Collaboration

Fostering value-driven partnerships through transparency, accountability, and ethical business practices.​

Ethics & Integrity

Integrating Industry 4.0 technologies, IoT-driven process controls, and advanced analytics for operational excellence.​

Commitment to Excellence 

Ensuring on-time, in-full (OTIF) execution with a customer-centric, project-driven approach. ​

Journey So Far

APDM Pharma has achieved significant milestones, marking its journey of innovation, growth, and excellence. Each accomplishment reflects the company’s unwavering commitment to advancing healthcare solutions.

June 2022

APDM Pharmaceuticals Founded

Inception of APDM Pharmaceuticals by a distinguished team of industry veterans and visionary leaders, marking the beginning of a transformative journey dedicated to pioneering healthcare innovations and pharmaceutical excellence on a global scale.

June 2022

Strategic Land Acquisition

Successful procurement of prime industrial land strategically chosen to support expansive infrastructure development, future growth, and optimized operational efficiencies for APDM Pharmaceuticals.

December 2022

Commencement of Plant Construction

Initiation of construction activities on APDM’s state-of-the-art pharmaceutical manufacturing facility, emphasizing adherence to global regulatory standards, sustainability practices, and cutting-edge design for superior production capabilities.

January - May 2023

Establishment of CDO and R&D Centre

Launch of a dedicated Contract Development Organization (CDO) and sophisticated Research and Development Centre, staffed by an expert team of over 50 seasoned scientists, laying the foundation for groundbreaking innovations, drug development, and next-generation pharmaceutical solutions.

May 2023

R&D Operations Begin, CDO Fully Functional

Official operational commencement of APDM’s advanced R&D Centre and CDO, actively engaged in intensive research projects, drug formulation advancements, and developmental initiatives poised to elevate healthcare solutions globally.

July 2023

Expansion of R&D Capabilities

Strategic expansion and augmentation of research and development facilities, enhancing APDM’s scientific capabilities, technological infrastructure, and fostering greater innovation to accelerate pharmaceutical breakthroughs.

Q3-Q4 2023

Accelerated Plant Construction and CAPEX Procurement

Intensified construction activities on the manufacturing facility coupled with the meticulous procurement of essential capital equipment (CAPEX), ensuring readiness for large-scale, high-quality pharmaceutical production.

June 2024

Completion of Main Manufacturing Facility

Successful completion and readiness of APDM’s main manufacturing facility, built to stringent international standards, ready to house advanced production technologies and ensure compliance with global regulatory requirements.

September 2024

Machinery Installation and Tech Transfers Initiated

Commencement of comprehensive machinery installation, incorporating advanced pharmaceutical technologies such as Wurster coaters, Extruders, and Spheronizers. 

Q1 2025

Machinery Installation and Tech Transfers Initiated

Formal inauguration and commissioning of APDM’s fully-equipped, regulatory-compliant manufacturing plant. Acquisition of two Abbreviated New Drug Applications (ANDAs), strategically positioning the company for accelerated regulatory approvals from international agencies including the USFDA, EMEA, and PIC/S, significantly expanding APDM’s global market reach and distribution capabilities.

R&D Manufacturing

At the core of APDM’s value proposition lies our state-of-the-art manufacturing and RD hub—a 15,000 sq. meterfacility near Ahmedabad. Outfitted with Wurster coaters, extruders, spheronizers, and IoT-driven control systems, this facility is designed to accommodate both novel formulations and large-scale production.

Facilities & Technology

Our facility boasts IoT-driven machinery and automated utilities, ensuring consistent quality and real-time data monitoring for unparalleled precision and efficiency. We’ve deliberately crafted a flexible environment that can handle everything from small-scale R&D prototypes to high-volume commercial batches, making us a versatile partner for diverse pharmaceutical needs.

Our Directors​

Our Advisors

Our Association

Leave us a message

We will get back to you within 2-3 business days